BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 22068166)

  • 1. Detection of pancreatic cancer tumours and precursor lesions by cathepsin E activity in mouse models.
    Cruz-Monserrate Z; Abd-Elgaliel WR; Grote T; Deng D; Ji B; Arumugam T; Wang H; Tung CH; Logsdon CD
    Gut; 2012 Sep; 61(9):1315-22. PubMed ID: 22068166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo diagnosis of murine pancreatic intraepithelial neoplasia and early-stage pancreatic cancer by molecular imaging.
    Eser S; Messer M; Eser P; von Werder A; Seidler B; Bajbouj M; Vogelmann R; Meining A; von Burstin J; Algül H; Pagel P; Schnieke AE; Esposito I; Schmid RM; Schneider G; Saur D
    Proc Natl Acad Sci U S A; 2011 Jun; 108(24):9945-50. PubMed ID: 21628592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic cancer-associated Cathepsin E as a drug activator.
    Abd-Elgaliel WR; Cruz-Monserrate Z; Wang H; Logsdon CD; Tung CH
    J Control Release; 2013 May; 167(3):221-7. PubMed ID: 23422726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Claudin-4-targeted optical imaging detects pancreatic cancer and its precursor lesions.
    Neesse A; Hahnenkamp A; Griesmann H; Buchholz M; Hahn SA; Maghnouj A; Fendrich V; Ring J; Sipos B; Tuveson DA; Bremer C; Gress TM; Michl P
    Gut; 2013 Jul; 62(7):1034-43. PubMed ID: 22677720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring pancreatic carcinogenesis by the molecular imaging of cathepsin E in vivo using confocal laser endomicroscopy.
    Li H; Li Y; Cui L; Wang B; Cui W; Li M; Cheng Y
    PLoS One; 2014; 9(9):e106566. PubMed ID: 25184278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNAs as diagnostic markers for pancreatic ductal adenocarcinoma and its precursor, pancreatic intraepithelial neoplasm.
    Xue Y; Abou Tayoun AN; Abo KM; Pipas JM; Gordon SR; Gardner TB; Barth RJ; Suriawinata AA; Tsongalis GJ
    Cancer Genet; 2013 Jun; 206(6):217-21. PubMed ID: 23933230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation of pancreatic ductal adenocarcinoma from chronic pancreatitis by PAM4 immunohistochemistry.
    Shi C; Merchant N; Newsome G; Goldenberg DM; Gold DV
    Arch Pathol Lab Med; 2014 Feb; 138(2):220-8. PubMed ID: 24476519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cathepsin E expression and activity: Role in the detection and treatment of pancreatic cancer.
    Pontious C; Kaul S; Hong M; Hart PA; Krishna SG; Lara LF; Conwell DL; Cruz-Monserrate Z
    Pancreatology; 2019 Oct; 19(7):951-956. PubMed ID: 31582345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative assessment of pancreatic cancer precursor lesions in IHC-stained tissue with a tissue image analysis platform.
    Aeffner F; Martin NT; Peljto M; Black JC; Major JK; Jangani M; Ports MO; Krueger JS; Young GD
    Lab Invest; 2016 Dec; 96(12):1327-1336. PubMed ID: 27775692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reg proteins promote acinar-to-ductal metaplasia and act as novel diagnostic and prognostic markers in pancreatic ductal adenocarcinoma.
    Li Q; Wang H; Zogopoulos G; Shao Q; Dong K; Lv F; Nwilati K; Gui XY; Cuggia A; Liu JL; Gao ZH
    Oncotarget; 2016 Nov; 7(47):77838-77853. PubMed ID: 27788482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting pancreatic ductal adenocarcinoma acidic microenvironment.
    Cruz-Monserrate Z; Roland CL; Deng D; Arumugam T; Moshnikova A; Andreev OA; Reshetnyak YK; Logsdon CD
    Sci Rep; 2014 Mar; 4():4410. PubMed ID: 24642931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-21 is induced early in pancreatic ductal adenocarcinoma precursor lesions.
    du Rieu MC; Torrisani J; Selves J; Al Saati T; Souque A; Dufresne M; Tsongalis GJ; Suriawinata AA; Carrère N; Buscail L; Cordelier P
    Clin Chem; 2010 Apr; 56(4):603-12. PubMed ID: 20093556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. mAb Das-1 identifies pancreatic ductal adenocarcinoma and high-grade pancreatic intraepithelial neoplasia with high accuracy.
    Das KK; Brown JW; Fernandez Del-Castillo C; Huynh T; Mills JC; Matsuda Y; Das KM; Mino-Kenudson M
    Hum Pathol; 2021 May; 111():36-44. PubMed ID: 33524436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of kallikrein-related peptidase 7 predicts poor prognosis in patients with unresectable pancreatic ductal adenocarcinoma.
    Iakovlev V; Siegel ER; Tsao MS; Haun RS
    Cancer Epidemiol Biomarkers Prev; 2012 Jul; 21(7):1135-42. PubMed ID: 22573795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of urocortin in pancreatic ductal adenocarcinoma and pancreatic intraepithelial neoplasia.
    Cheng MF; Tsai WC; Hsia KT; Yang YS; Jin JS
    APMIS; 2014 Feb; 122(2):147-54. PubMed ID: 23755913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNAs for Detection of Pancreatic Neoplasia: Biomarker Discovery by Next-generation Sequencing and Validation in 2 Independent Cohorts.
    Vila-Navarro E; Vila-Casadesús M; Moreira L; Duran-Sanchon S; Sinha R; Ginés À; Fernández-Esparrach G; Miquel R; Cuatrecasas M; Castells A; Lozano JJ; Gironella M
    Ann Surg; 2017 Jun; 265(6):1226-1234. PubMed ID: 27232245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of pancreatic ductal adenocarcinoma in mice by ultrasound imaging of thymocyte differentiation antigen 1.
    Foygel K; Wang H; Machtaler S; Lutz AM; Chen R; Pysz M; Lowe AW; Tian L; Carrigan T; Brentnall TA; Willmann JK
    Gastroenterology; 2013 Oct; 145(4):885-894.e3. PubMed ID: 23791701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The silencing of microRNA 148a production by DNA hypermethylation is an early event in pancreatic carcinogenesis.
    Hanoun N; Delpu Y; Suriawinata AA; Bournet B; Bureau C; Selves J; Tsongalis GJ; Dufresne M; Buscail L; Cordelier P; Torrisani J
    Clin Chem; 2010 Jul; 56(7):1107-18. PubMed ID: 20431052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant expression of a disintegrin and metalloproteinase 17/tumor necrosis factor-alpha converting enzyme increases the malignant potential in human pancreatic ductal adenocarcinoma.
    Ringel J; Jesnowski R; Moniaux N; Lüttges J; Ringel J; Choudhury A; Batra SK; Klöppel G; Löhr M
    Cancer Res; 2006 Sep; 66(18):9045-53. PubMed ID: 16982746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MALDI imaging mass spectrometry for in situ proteomic analysis of preneoplastic lesions in pancreatic cancer.
    Grüner BM; Hahne H; Mazur PK; Trajkovic-Arsic M; Maier S; Esposito I; Kalideris E; Michalski CW; Kleeff J; Rauser S; Schmid RM; Küster B; Walch A; Siveke JT
    PLoS One; 2012; 7(6):e39424. PubMed ID: 22761793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.